Narrow search
Showing 1 - 7 of 7
Cover Image
Italian risk-sharing agreements on drugs : are they worthwhile?
Garattini, Livio; Curto, Alessandro; Van de Vooren, … - In: The European journal of health economics : HEPAC ; … 16 (2015) 1, pp. 1-3
Persistent link: https://www.econbiz.de/10011300361
Cover Image
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio; Curto, Alessandro; Van de Vooren, … - In: The European journal of health economics : HEPAC ; … 16 (2015) 7, pp. 683-687
Persistent link: https://www.econbiz.de/10011482938
Cover Image
Could co-payments on drugs help to make EU health care systems less open to political influence?
Garattini, Livio; Van de Vooren, Katelijne - In: The European journal of health economics : HEPAC ; … 14 (2013) 5, pp. 709-713
Persistent link: https://www.econbiz.de/10010195586
Cover Image
HTA for pharmaceuticals in Europe : will the mountain deliver a mouse?
Garattini, Livio; Padula, Anna - In: The European journal of health economics : HEPAC ; … 21 (2020) 1, pp. 1-5
Persistent link: https://www.econbiz.de/10012221579
Cover Image
Pricing vaccines and drugs in Europe : worth differentiating?
Garattini, Livio; Padula, Anna; Freemantle, Nicholas - In: The European journal of health economics 22 (2021) 9, pp. 1345-1348
Persistent link: https://www.econbiz.de/10012665833
Cover Image
Competition in pharmaceuticals : more product- than price‑oriented?
Garattini, Livio; Padula, Anna - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 1-4
Persistent link: https://www.econbiz.de/10011945818
Cover Image
Pharmaceutical pricing conundrum : time to get rid of it?
Garattini, Livio; Padula, Anna - In: The European journal of health economics : HEPAC ; … 19 (2018) 8, pp. 1035-1038
Persistent link: https://www.econbiz.de/10011948132